Skip Navigation
menu
search
Sign-ons
CyMail
Outlook
Canvas
AccessPlus
Workday
More
Directory
Maps
Contact Us
Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Office of Sponsored Programs Administration
menu
Home
Streamlyne
Proposals/Pre-Award
Awards/Post-Award
Policies
Forms
Training
News
OSPA News
Funding opportunities
Tools
Sponsor Requirements
Sponsored Funding & COVID-19
Request an MTA or NDA
Contact Us
The following are aggregates from select government RSS feeds regarding various funding opportunities.
National Science Foundation - Program Announcements and Information
Dear Colleague Letter: Announcing the Opportunity for NSF Researchers to Participate in BioMADE Project Calls as Part of an Integrated Project Team
Addressing Systems Challenges through Engineering Teams (ASCENT)
Organismal Response to Climate Change (ORCC)
NSF call for IUCRC (Industry-University Cooperative Research Center) Proposals for a Center Pursuing Optical Tissue-mimicking Phantoms for Biomedical Applications
Dear Colleague Letter: NSF call for IUCRC (Industry-University Cooperative Research Center) Proposals for a Center Pursuing Optical Tissue-mimicking Phantoms for Biomedical Applications
National Science Foundation - Upcoming Due Dates
PFE: Research Initiation in Engineering Formation (PFE: RIEF)
Discovery Research PreK-12 (DRK-12)
Collaborative Research in Computational Neuroscience (CRCNS)
NSF National Resource Coordination Center on Improving Undergraduate STEM Education (IUSE) (IUSE Center)
Historically Black Colleges and Universities Undergraduate Program (HBCU-UP)
National Institutes of Health - Funding Opportunities
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required)
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed)